Drug Shortage Report for MORPHINE SULFATE INJECTION EPIDURAL

Last updated on 2023-05-23 History
Report ID 185528
Drug Identification Number 02498278
Brand name MORPHINE SULFATE INJECTION EPIDURAL
Common or Proper name MORPHINE SULFATE INJECTION EPIDURAL
Company Name STERIMAX INC
Market Status MARKETED
Active Ingredient(s) MORPHINE SULFATE
Strength(s) 0.5MG
Dosage form(s) SOLUTION
Route of administration EPIDURAL
Packaging size 0.5 MG/ML 10 ML
ATC code N02AA
ATC description OPIOIDS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2023-02-20
Estimated end date 2023-05-19
Actual end date 2023-05-19
Shortage status Resolved
Updated date 2023-05-23
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2770 PORTLAND DRIVE
OAKVILLE, ONTARIO
CANADA L6H 6R4
Company contact information 1-800-881-3550

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2023-05-23 French Compare
v11 2023-05-23 English Compare
v10 2023-05-19 French Compare
v9 2023-05-19 English Compare
v8 2023-05-04 French Compare
v7 2023-05-04 English Compare
v6 2023-04-25 French Compare
v5 2023-04-25 English Compare
v4 2023-03-29 French Compare
v3 2023-03-29 English Compare
v2 2023-02-23 French Compare
v1 2023-02-23 English Compare

Showing 1 to 12 of 12